587 related articles for article (PubMed ID: 35538061)
1. Artificial intelligence in cancer target identification and drug discovery.
You Y; Lai X; Pan Y; Zheng H; Vera J; Liu S; Deng S; Zhang L
Signal Transduct Target Ther; 2022 May; 7(1):156. PubMed ID: 35538061
[TBL] [Abstract][Full Text] [Related]
2. Role of Artificial Intelligence in Drug Discovery and Target Identification in Cancer.
Sharma V; Singh A; Chauhan S; Sharma PK; Chaudhary S; Sharma A; Porwal O; Fuloria NK
Curr Drug Deliv; 2024; 21(6):870-886. PubMed ID: 37670704
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive review on recent approaches for cancer drug discovery associated with artificial intelligence.
Pandiyan S; Wang L
Comput Biol Med; 2022 Nov; 150():106140. PubMed ID: 36179510
[TBL] [Abstract][Full Text] [Related]
4. Artificial intelligence-guided discovery of anticancer lead compounds from plants and associated microorganisms.
Li G; Lin P; Wang K; Gu CC; Kusari S
Trends Cancer; 2022 Jan; 8(1):65-80. PubMed ID: 34750090
[TBL] [Abstract][Full Text] [Related]
5. Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery.
Nayarisseri A; Khandelwal R; Tanwar P; Madhavi M; Sharma D; Thakur G; Speck-Planche A; Singh SK
Curr Drug Targets; 2021; 22(6):631-655. PubMed ID: 33397265
[TBL] [Abstract][Full Text] [Related]
6. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
Yang X; Wang Y; Byrne R; Schneider G; Yang S
Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
[TBL] [Abstract][Full Text] [Related]
7. Application of Computational Biology and Artificial Intelligence Technologies in Cancer Precision Drug Discovery.
Nagarajan N; Yapp EKY; Le NQK; Kamaraj B; Al-Subaie AM; Yeh HY
Biomed Res Int; 2019; 2019():8427042. PubMed ID: 31886259
[TBL] [Abstract][Full Text] [Related]
8. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
[TBL] [Abstract][Full Text] [Related]
9. Artificial intelligence for natural product drug discovery.
Mullowney MW; Duncan KR; Elsayed SS; Garg N; van der Hooft JJJ; Martin NI; Meijer D; Terlouw BR; Biermann F; Blin K; Durairaj J; Gorostiola González M; Helfrich EJN; Huber F; Leopold-Messer S; Rajan K; de Rond T; van Santen JA; Sorokina M; Balunas MJ; Beniddir MA; van Bergeijk DA; Carroll LM; Clark CM; Clevert DA; Dejong CA; Du C; Ferrinho S; Grisoni F; Hofstetter A; Jespers W; Kalinina OV; Kautsar SA; Kim H; Leao TF; Masschelein J; Rees ER; Reher R; Reker D; Schwaller P; Segler M; Skinnider MA; Walker AS; Willighagen EL; Zdrazil B; Ziemert N; Goss RJM; Guyomard P; Volkamer A; Gerwick WH; Kim HU; Müller R; van Wezel GP; van Westen GJP; Hirsch AKH; Linington RG; Robinson SL; Medema MH
Nat Rev Drug Discov; 2023 Nov; 22(11):895-916. PubMed ID: 37697042
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.
Vatansever S; Schlessinger A; Wacker D; Kaniskan HÜ; Jin J; Zhou MM; Zhang B
Med Res Rev; 2021 May; 41(3):1427-1473. PubMed ID: 33295676
[TBL] [Abstract][Full Text] [Related]
11. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
Kashyap K; Siddiqi MI
Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
[TBL] [Abstract][Full Text] [Related]
12. Drug Intelligence Science (DIS®): Pioneering a high-resolution translational platform to enhance the probability of success for drug discovery and development.
Schweizer L
Drug Discov Today; 2023 Nov; 28(11):103795. PubMed ID: 37805064
[TBL] [Abstract][Full Text] [Related]
13. From machine learning to deep learning: progress in machine intelligence for rational drug discovery.
Zhang L; Tan J; Han D; Zhu H
Drug Discov Today; 2017 Nov; 22(11):1680-1685. PubMed ID: 28881183
[TBL] [Abstract][Full Text] [Related]
14. A novel artificial intelligence protocol to investigate potential leads for diabetes mellitus.
Gong JN; Zhao L; Chen G; Chen X; Chen ZD; Chen CY
Mol Divers; 2021 Aug; 25(3):1375-1393. PubMed ID: 33687591
[TBL] [Abstract][Full Text] [Related]
15. Artificial Intelligence and Cancer Drug Development.
Yang F; Darsey JA; Ghosh A; Li HY; Yang MQ; Wang S
Recent Pat Anticancer Drug Discov; 2022; 17(1):2-8. PubMed ID: 34323201
[TBL] [Abstract][Full Text] [Related]
16. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
Koromina M; Pandi MT; Patrinos GP
OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
[TBL] [Abstract][Full Text] [Related]
17. Machine and deep learning approaches for cancer drug repurposing.
Issa NT; Stathias V; Schürer S; Dakshanamurthy S
Semin Cancer Biol; 2021 Jan; 68():132-142. PubMed ID: 31904426
[TBL] [Abstract][Full Text] [Related]
18. Machine learning approaches and their applications in drug discovery and design.
Priya S; Tripathi G; Singh DB; Jain P; Kumar A
Chem Biol Drug Des; 2022 Jul; 100(1):136-153. PubMed ID: 35426249
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic discovery in the artificial intelligence era.
Lluka T; Stokes JM
Ann N Y Acad Sci; 2023 Jan; 1519(1):74-93. PubMed ID: 36447334
[TBL] [Abstract][Full Text] [Related]
20. Machine Learning Empowering Drug Discovery: Applications, Opportunities and Challenges.
Qi X; Zhao Y; Qi Z; Hou S; Chen J
Molecules; 2024 Feb; 29(4):. PubMed ID: 38398653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
